Tribute Pharmaceuticals Canada Inc. is an emerging Canadian specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada. The Company targets several therapeutic areas in Canada with a particular interest in products for the treatment of neurology, pain, urology, dermatology and endocrinology/cardiology. In addition to developing and selling healthcare products in Canada, Tribute also sells products globally through a number of international partners.
Company profile
Ticker
SLRXF
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Stellar International Inc, Stellar Pharmaceuticals Inc
SEC CIK
Corporate docs
Latest filings (excl ownership)
UPLOAD
Letter from SEC
22 Mar 16
15-12G
Securities registration termination
12 Feb 16
8-K
Entry into a Material Definitive Agreement
11 Feb 16
EFFECT
Notice of effectiveness
8 Feb 16
EFFECT
Notice of effectiveness
8 Feb 16
EFFECT
Notice of effectiveness
8 Feb 16
8-K
Regulation FD Disclosure
5 Feb 16
D
$75M in equity, sold $75M, 7 investors
5 Feb 16
D
$75M in debt / options / securities to be acquired, sold $75M, 3 investors
5 Feb 16
POS AM
Prospectus update (post-effective amendment)
5 Feb 16
Latest ownership filings
SC 13G
Tribute Pharmaceuticals Canada Inc.
16 Feb 16
SC 13G/A
Tribute Pharmaceuticals Canada Inc.
10 Sep 15
SC 13G/A
Tribute Pharmaceuticals Canada Inc.
10 Jun 15
SC 13D
Tribute Pharmaceuticals Canada Inc.
24 Mar 15
SC 13D
Tribute Pharmaceuticals Canada Inc.
18 Mar 15
SC 13D/A
Tribute Pharmaceuticals Canada Inc.
16 Mar 15
SC 13D/A
Tribute Pharmaceuticals Canada Inc.
27 Feb 15
SC 13G/A
Tribute Pharmaceuticals Canada Inc.
13 Feb 15
SC 13G
Tribute Pharmaceuticals Canada Inc.
10 Oct 14
SC 13D/A
SJ STRATEGIC INVESTMENTS LLC
11 Mar 13